Israel’s TA-25 Index increased to the highest level since May 22, advancing 0.7 percent to 1,268.44 at the 4:30 p.m. close in Tel Aviv. Investors traded about 888.5 million shekels ($261.3 million) in shares and convertible securities.
The following stocks rose or fell today. Symbols are in parentheses.
Glycominds Ltd. (GLCM IT) soared the most since shares listed in March, climbing 18 percent to 1.227 shekels. The molecular-diagnostics company said it received approval from three more U.S. states to market its multiple sclerosis blood test.
Habas H.Z. Investments (1960) Ltd. (HBS IT) advanced 4.7 percent to 8.269 shekels, the highest since May 1. The board of the international investment and holding company approved paying an annual dividend of 25 percent of profit and declared a 30 million-shekel distribution, payable Aug. 1.
Separately, the company said it plans a bond sale and exchange offer for some of its outstanding bonds.
Kamor Motors Ltd. (KMRS) surged the most since at least November 2006 when Bloomberg began tracking the shares, soaring 31 percent to 16.40 shekels. The controlling shareholders of the importer of BMW vehicles to Israel said they were in talks to sell their stakes to Delek Automotive Systems Ltd. (DLEA) based on a value of 245 million shekels ($72 million). Kamor Ltd. (KMOR) , which owns about 64 percent of Kamor Motors, jumped 5.1 percent to 9.461 shekels, the highest since May 2010. Delek Automotive increased 3.6 percent, the most in a week, to 37.98 shekels.
Medigus Ltd. (MDGS) climbed 16 percent to 0.946 shekel, the biggest increase since August 2009. The developer of procedures and devices to treat gastro-esophageal reflux disease received the preliminary results of the final clinical trial of its endoscopy system.
Ophir Optronics Ltd. (OPIR) advanced the most since at least February 1996, when Bloomberg began tracking the shares, rising 73 percent to 25.90 shekels. The maker of optical instruments agreed to be acquired by Newport Corp. for $230 million.
To contact the editor responsible for this story: Claudia Maedler at email@example.com